Sanders Morris Harris’s TherapeuticsMD TXMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-25,000
Closed -$75.5K 247
2023
Q3
$75.5K Hold
25,000
0.02% 244
2023
Q2
$103K Sell
25,000
-8,577
-26% -$35.3K 0.02% 242
2023
Q1
$126K Sell
33,577
-6,816
-17% -$25.6K 0.04% 129
2022
Q4
$226K Hold
40,393
0.09% 176
2022
Q3
$268K Buy
+40,393
New +$268K 0.07% 215
2022
Q2
Sell
-10,253
Closed -$194K 308
2022
Q1
$194K Sell
10,253
-30
-0.3% -$568 0.04% 271
2021
Q4
$183K Sell
10,283
-60,933
-86% -$1.08M 0.03% 281
2021
Q3
$2.64M Buy
71,216
+2,400
+3% +$89K 0.48% 40
2021
Q2
$4.1M Sell
68,816
-1,620
-2% -$96.4K 0.8% 21
2021
Q1
$4.72M Sell
70,436
-11,866
-14% -$795K 1% 19
2020
Q4
$4.98M Sell
82,302
-3,631
-4% -$220K 1.13% 16
2020
Q3
$6.79M Buy
85,933
+11,282
+15% +$891K 1.84% 8
2020
Q2
$4.67M Sell
74,651
-401
-0.5% -$25.1K 2.27% 11
2020
Q1
$4K Buy
75,052
+67,632
+911% +$3.61K ﹤0.01% 129
2019
Q4
$1.81M Sell
7,420
-12,696
-63% -$3.09M 0.41% 66
2019
Q3
$3.65M Buy
20,116
+12,906
+179% +$2.34M 0.88% 22
2019
Q2
$937K Sell
7,210
-210
-3% -$27.3K 0.24% 89
2019
Q1
$1.81M Sell
7,420
-1,350
-15% -$329K 0.88% 25
2018
Q4
$1.67M Buy
8,770
+170
+2% +$32.4K 0.92% 25
2018
Q3
$2.82M Sell
8,600
-140
-2% -$45.9K 1.32% 21
2018
Q2
$2.73M Sell
8,740
-1,290
-13% -$402K 1.26% 21
2018
Q1
$2.44M Sell
10,030
-400
-4% -$97.4K 1.02% 24
2017
Q4
$3.15M Sell
10,430
-446
-4% -$135K 1.33% 18
2017
Q3
$2.88M Sell
10,876
-346
-3% -$91.5K 1.23% 22
2017
Q2
$2.96M Buy
11,222
+1,550
+16% +$408K 1.21% 21
2017
Q1
$3.48M Sell
9,672
-110
-1% -$39.6K 1.27% 17
2016
Q4
$2.82M Sell
9,782
-340
-3% -$98.1K 1.31% 15
2016
Q3
$3.45M Buy
10,122
+1,610
+19% +$548K 1.05% 24
2016
Q2
$3.62M Buy
8,512
+7,092
+499% +$3.01M 0.84% 18
2016
Q1
$454K Buy
+1,420
New +$454K 0.08% 196